Join the Xycota brain health & neuro-regeneration movement

Follow Xycota's preclinical central-nervous-system research alongside veterans, first responders, clinicians, patient and family advocates, athletes, and long-term supporters.

Before You Sign Up · How the Community List Works

Become a Xycota movement ambassador

Here is exactly what you receive, what participation involves, and which parts are optional before you enter your name and email:

01 · What You Receive

Plain-language research digests on BDNF/TrkB and exosome science, release notices for The Battlefield & The Brain (launching 2027), and public corporate milestones.

02 · What Participation Involves

Email updates matched to the primary perspective you select below. There is no cost, no quota, and you can unsubscribe at any time with one click.

03 · What Is Optional

Sharing public educational articles, attending open community Q&As, selecting a primary advocacy perspective, or listing an organization.

Separate from trial enrollment & investor qualification: Community Ambassador signup is for public educational and corporate updates only. It is not clinical-trial enrollment or medical care (no clinical trial is currently recruiting), and it is separate from institutional investor qualification (accredited and institutional investors can request diligence access in the Data Room).

Full Name *

Email Address *

Primary Ambassador Track (Optional)

Gym, Team, Clinic, VSO, or Organization (Optional)

Areas of Interest (Optional)

Peer-Reviewed BDNF/TrkB & Exosome Neuro-Repair Research The Battlefield & The Brain Podcast (Service, Arena & Brain Health) mTBI, Concussion & Long-Term Brain Resilience Science Regulatory and research milestones

I consent to receive Movement Ambassador updates from Xycota Biosciences, LLC. I can unsubscribe at any time. * I have read the Regulatory and Public-Information Disclosures below. *

For details on how optional self-identified advocacy preferences are handled, see our Consumer Health Data Privacy Policy.

Questions? community@xycota.com

FDA 21 CFR § 312.7 Investigational Notice: XYCO-01 and XYCO-02 are preclinical, investigational programs not approved by the US FDA, Health Canada, or any regulatory authority. All references to mild traumatic brain injury (mTBI), concussion, PTSD, and FTD reflect preclinical scientific exploration and educational disease awareness only; no clinical safety or therapeutic efficacy is claimed. Nothing in the Xycota Movement Ambassador Program constitutes medical advice or clinical trial recruitment.

SEC Regulation FD & Public Parity Notice: All corporate announcements, clinical milestones, and leadership Q&A sessions are made concurrently available to all shareholders and the general public via public press releases and filings. Movement Ambassadors receive zero compensation, shares, points, or consideration for joining or sharing public educational content. Contact: community@xycota.com.

Are you a BioAdaptives (OTCID: BDPT) shareholder? The shareholder program is separate. Visit the shareholder page →